News article by the Centre for Genomic Pathogen Surveillance — 27 April 2020
Pathogen surveillance is a crucial part of early-stage and ongoing responses to COVID-19.
The UK consortium on COVID-19 genomics (COG) aims to link local sequencing centres with large scale facilities from across the UK to apply real-time genomic epidemiology to our understanding and ability to respond to the pandemic.
CGPS is pleased to be a core partner in COG (cogconsortium.uk) delivering large-scale and rapid whole-genome virus sequencing to inform UK response.
Through a £20 million investment, the consortium looks for breakthroughs that help the UK respond to this and future pandemics, and save lives.
The Government and the UK’s Chief Scientific Adviser have backed the UK’s leading clinicians and scientists to map how COVID-19 spreads and evolves using whole-genome sequencing.
Data Analysis, phylogenetics and delivery of insight for decision making is a key component of the project. The CGPS team is bringing expertise in data handling, processing, linking and visualisation to enhance the delivery of data and interpretation using tools such as Microreact, EpiCollect and Data-flo.
